Rhythm Biosciences is an innovative Australian medical diagnostics company that specializes in developing simple and accurate blood tests for the detection of cancer. As a publicly listed company, their mission is to save lives through early cancer detection using advanced diagnostic technology. Their flagship product, ColoSTAT®, is a simple blood-based test designed for the early detection of colorectal cancer.

This test provides a reliable alternative screening option for individuals who are unable or unwilling to undergo traditional screening methods. Rhythm Biosciences is dedicated to collaborating with like-minded global partners to ensure the commercialization and distribution of these user-friendly solutions. With a timeline that spans from 2003 to present, Rhythm Biosciences has made significant strides in their research and development efforts.

They have secured patents in 21 countries, obtained ISO certification, and received important regulatory approvals such as the CE Mark for ColoSTAT®. They are also actively exploring the feasibility of using their proprietary immunoassay technology to develop diagnostic tests for other types of cancers. Located at the Bio21 Institute in Parkville, VIC, Rhythm Biosciences is committed to providing physicians with the most reliable and accurate diagnostic tools to improve patient outcomes and reduce the global burden of cancer.

Stay connected with Rhythm Biosciences to stay informed about their groundbreaking advancements in cancer detection